Q&A

Can you guess what condition Tiny Tim had?

This week the panel weighs in on monoclonal antibodies in this patient population as well as important overall takeaways about COVID-19 therapies.

The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.